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ABSTRACT
The mitochondrial lipidome influences ETC (electron
transport chain) and cellular bioenergetic efficiency.
Brain tumours are largely dependent on glycolysis for
energy due to defects in mitochondria and oxidative
phosphorylation. In the present study, we used shotgun
lipidomics to compare the lipidome in highly purified
mitochondria isolated from normal brain, from brain
tumour tissue, from cultured tumour cells and from non-
tumorigenic astrocytes. The tumours included the CT-2A
astrocytoma and an EPEN (ependymoblastoma), both
syngeneic with the C57BL/6J (B6) mouse strain. The
mitochondrial lipidome in cultured CT-2A and EPEN
tumour cells were compared with those in cultured
astrocytes and in solid tumours grown in vivo.M a j o r
differences were found between normal tissue and
tumour tissue and between in vivo and in vitro growth
environments for the content or composition of ethano-
lamine glycerophospholipids, phosphatidylglycerol and
cardiolipin. The mitochondrial lipid abnormalities in solid
tumours and in cultured cells were associated with
reductions in multiple ETC activities, especially Complex I.
The in vitro growth environment produced lipid and ETC
abnormalities in cultured non-tumorigenic astrocytes
that were similar to those associated with tumorigenicity.
It appears that the culture environment obscures the
boundaries of the Crabtree and the Warburg effects.
These results indicate that in vitro growth environments
can produce abnormalities in mitochondrial lipids and ETC
activities, thus contributing to a dependency on glycolysis
for ATP production.
Key words: cancer, culture, glycolysis, lipid, metabolism,
shotgun lipidomics.
INTRODUCTION
Brain tumours depend heavily on glycolysis to supply ATP for
growth and cellular function (Kirsch et al., 1972; Galarraga et
al., 1986; Lichtor and Dohrmann, 1986; Floridi et al., 1989;
Oudard et al., 1997; Seyfried and Mukherjee, 2005). An
irreversible injury to cellular respiration is proposed to
underlie the dependence of tumours on glycolytic energy
(Warburg, 1956; Kiebish et al., 2008a). Structural defects in
brain tumour mitochondria have been described and involve
swelling, morphological deformities and cristolysis (Cervos-
Navarro et al., 1981; Oudard et al., 1997; Arismendi-Morillo
and Castellano-Ramirez, 2008). These defects suggest an
impaired ability of mitochondria to effectively produce ATP
via oxidative phosphorylation. Mitochondrial membrane
lipids are critical for regulating a variety of functions,
including membrane fluidity/stability, proton gradient
impermeability, membrane potential, ETC (electron trans-
1To whom correspondence should be addressed (email Thomas.Seyfried@bc.edu).
Abbreviations: Cer, ceramide; CerPCho, sphingomyelin; ChoGpl, choline glycerophospholipids; EPEN, ependymoblastoma; ESI/MS, electrospray ionization/MS; ETC, electron
transport chain; EtnGpl, ethanolamine glycerophospholipids; lysoPtdCho, lysophosphatidylcholine; MS/MS, tandem MS; NS, non-synaptic; PakCho, plasmanylcholine; PakEtn,
plasmanylethanolamine; PlsCho, plasmenylcholine; PlsEtn, plasmenylethanolamine; PtdCho, phosphatidylcholine; PtdEtn, phosphatidylethanolamine; PtdGro,
phosphatidylglycerol; PtdIns, phosphatidylinositol; PtdSer, phosphatidylserine.
E 2009 The Author(s) The Authors(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://
creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is
properly cited.
RESEARCH ARTICLE
ASN NEURO 1(3):art:e00011.doi:10.1042/AN20090011
asnneuro.org / Volume 1 (3) / art:e00011 125port chain) activities, supercomplex formation and proton
leak (Daum, 1985; McMillin and Dowhan, 2002; Zhang et al.,
2002). Also, the unique composition of mitochondrial lipids
in both the inner and the outer membranes is required for
efficient ATP production (Mileykovskaya et al., 2005).
Abnormalities in mitochondrial lipid composition could
produce uncoupling and impaired energy production,
despite continued CO2 production and O2 consumption
(Wu et al., 2007).
EtnGpl (ethanolamine glycerophospholipids) and ChoGpl
(choline glycerophospholipids) comprise nearly 80% of the
total phospholipids in the mitochondrial lipidome (Daum,
1985; Kiebish et al., 2008b). Other mitochondrial lipids in
order of abundance include cardiolipin, PtdIns (phosphatidyl-
inositol), PtdSer (phosphatidylserine), PtdGro (phosphatidyl-
glycerol), CerPCho (sphingomyelin), lysoPtdCho (lysophos-
phatidylcholine) and Cer (ceramide) (Kiebish et al., 2008c).
Each phospholipid contains a unique distribution of fatty acid
molecular species in the sn-1 and sn-2 positions. Lipids of
tumour mitochondria generally contain fatty acids with
shorter chain lengths and less unsaturation than lipids of
normal tissue mitochondria (Morton et al., 1976; Reitz et al.,
1977; Hartz et al., 1982; Canuto et al., 1989; Peskin and
Carter, 2008). These fatty acid changes alter mitochondrial
membrane fluidity, which lowers bioenergetic efficiency (Ellis
et al., 2005). In addition to abnormalities in fatty acid species
composition, neoplastic tissues also contain abnormalities in
the content of specific lipids, including cardiolipin,
lysoPtdCho, PtdSer and CerPCho, as well as ether glycerophos-
pholipids (Bergelson et al., 1970, 1974; Hostetler et al., 1979).
The advent of shotgun lipidomics using ESI/MS (electrospray
ionization/MS) now provides a rapid and quantitative method
for the comprehensive analysis of membrane lipids from
normal and diseased tissues even with a limited amount of
sample (Han and Gross, 2005).
Cardiolipin is almost exclusively localized in the inner
membrane of mitochondria where it is synthesized from
condensation of PtdGro and cytidine diphosphate-diacylgly-
cerol to form immature cardiolipin (Hoch, 1992; Schlame et
al., 2000). Mature cardiolipin is then formed through a
remodelling process involving deacylation and reacylation
reactions using donor fatty acids from EtnGpl, ChoGpl and
acyl-CoA (Hauff and Hatch, 2006; Kiebish et al., 2008c).
Tetralinoleic cardiolipin is the predominant remodelled
cardiolipin in heart, liver and muscle, which is maintained
by a selective remodelling process (Schlame et al., 2005).
Abnormalities in cardiolipin molecular species composition, as
found in Barth syndrome, produce severe impairments in
oxidative phosphorylation and energy metabolism (Schlame
and Ren, 2006). Thus maintenance of cardiolipin molecular
species composition is critical for bioenergetic capacity.
In contrast with the predominant tetralinoleic cardiolipin
found in most non-neural tissues, cardiolipin in brain
mitochondria is comprised of over 100 fatty acid molecular
species (Schlame et al., 2005; Cheng et al., 2008; Kiebish et
al., 2008b). Moreover, these molecular species are distributed
in seven major groups when arranged according to mass-to-
charge ratios (Kiebish et al., 2008b). It is unknown which
specific acyltransferase(s), transacylase(s) or phospholipase(s)
are involved in the remodelling of brain cardiolipin.
Regardless, the cardiolipin remodelling machinery should be
similar in all cells derived from neural origin, resulting in the
increased molecular species distribution as found for brain
cardiolipin. If lipid or fatty acid metabolism is altered in brain
tumour mitochondria, then the resulting effects will be
evident in cardiolipin remodelling due to utilization of donor
fatty acids. Abnormalities in cardiolipin remodelling will also
reduce ATP production through oxidative phosphorylation,
thus altering bioenergetic capacity.
The present study is the first to analyse the mitochondrial
lipidome of experimental brain tumours grown in vivo and in
vitro. We have also compared the lipidome of the cultured
brain tumour cells with that of non-tumorigenic syngeneic
astrocytes. ETC activities were measured in isolated mito-
chondria to determine whether these brain tumour mito-
chondria have an impaired ability to produce ATP by oxidative
phosphorylation. The results show that abnormalities in the
mitochondrial lipidome can arise from tumorigenicity, as well
as from the in vitro growth environment.
MATERIALS AND METHODS
Mice and brain tumours
The inbred C57BL/6J (B6) mouse strain was obtained from the
Jackson Laboratory. B6 mice were propagated at the Boston
College Animal Facility and were housed in plastic cages with
filter tops containing Sani-Chip bedding (P.J. Murphy Forest
Products). The room was maintained at 22˚C on a 12 h/12 h
light/dark cycle. Food (Prolab RMH 3000; PMI LabDiet) and
water were provided ad libitum. The present study was
conducted according to the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and was
approved by the Institutional Animal Care Committee.
The CT-2A and EPEN (ependymoblastoma) brain tumours
were originally produced from the implantation of 20-
methylcholanthrene into the brains of B6 mice as previously
described (Zimmerman and Arnould, 1941; Seyfried et al.,
1992). The CT-2A tumour arose in the cerebral cortex and was
characterized as a malignant anaplastic astrocytoma, whereas
the EPEN tumour arose in the cerebral ventricle and was
characterized as an ependymoblastoma (Rubin and Sutton,
1968; Seyfried et al., 1992). Male B6 mice (8–12 weeks of age)
were used as tumour recipients. Tumour pieces from donor
mice were diced and resuspended in ice-cold PBS at pH 7.4.
Mice were anaesthetized with isoflurane (Halocarbon) and 0.1
ml of diced tumour tissue suspended in 0.2 ml of PBS was
implanted subcutaneously in the right flank by injection
using a 1 cc tuberculin syringe and an 18-gauge needle.
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The cultured cell lines were prepared from the CT-2A and
EPEN tumours as described previously (Seyfried et al., 1992;
El-Abbadi and Seyfried, 1994; Bai and Seyfried, 1997). The
C8-D1A type 1 astrocyte cell line was purchased from
A.T.C.C. The genetic background of these cells is highly
similar to that of the tumour cells since the C8-D1A cells
were isolated initially from the cerebella of 8-day-old
C57BL/6 mice (Alliot and Pessac, 1984). It is important to
mention that no carcinogens or viruses were used to
transform the C8-D1A cells. Although the authors described
the cells as arising from spontaneous transformation, this is
debatable, as the event(s) responsible for the onset of cell
growth was similar to that in cultures originating from 1-
and 15-day postnatal mouse cerebellum (Alliot and Pessac,
1984). All cultured cells were maintained under identical
conditions in DMEM (Dulbecco’s modified Eagle’s medium;
Sigma) supplemented with 10% (v/v) FBS (fetal bovine
serum; Atlanta Biologicals), 25 mM glucose and 0.5%
penicillin/streptomycin (Sigma) in a humidified atmosphere
containing 95% air and 5% CO2 at 37˚C. Cells were grown
to 90% confluency and removed using a BD Falcon cell
scraper (Becton Dickinson).
Mitochondrial isolation
Mitochondria were isolated in a cold room (4˚C) and all
reagents were kept on ice. NS (non-synaptic) mouse brain
mitochondria and brain tumour mitochondria were isolated
as previously described using a series of discontinuous Ficoll
and sucrose gradients (Kiebish et al., 2008b, 2008c). Briefly,
the cerebral cortexes (a pool of six/sample) or a pool of four
tumours/sample were homogenized on ice and differentially
centrifuged to remove membrane contamination. A crude
mitochondrial pellet was layered on a 7.5%/12% Ficoll
discontinuous gradient and centrifuged at 73000 g for 36
min in a Sorval SW 28 rotor. An enriched mitochondrial pellet
was collected below the 12% Ficoll layer. The enriched
mitochondrial pellet was then layered on a 0.8 M/1.0 M/1.3
M/1.6 M discontinuous sucrose gradient and centrifuged at
50000 g for 2 h in a Sorvall SW 28 rotor. Purified NS brain or
brain tumour mitochondria were collected at the interface
between 1.3 M and 1.6 M sucrose.
Mitochondria were isolated from the cultured CT-2A, EPEN
and non-tumorigenic astrocytes cell lines as a single enriched
mitochondrial fraction as previously described (Yang et al.,
1997; Pon and Schon, 2001). A pellet obtained from cells
grown to 90% confluency on six T150 flasks was resuspended
in MIB [mitochondrial isolation buffer; 0.32 M sucrose, 10
mM Tris/HCl and 1 mM potassium EDTA (pH 7.4)] and
homogenized on ice using a teflon-coated homogenizer
attached to a hand-held drill. Samples were homogenized
using ten up and down strokes at 500 rev./min. The
homogenate was then centrifuged at 800 g for 5 min. The
supernatant was collected and centrifuged at 1000 g for 5
min. The pellet was discarded and the supernatant was
collected and centrifuged at 14000 g for 10 min. The pellet
was collected and resuspended in MIB and recentrifuged at
8600 g for 10 min. The supernatant was discarded and the
pellet was resuspended in MIB and layered on a 0.8 M/1.0 M/
1.7 M discontinuous sucrose gradient and centrifuged at
80000 g for 2 h in a Sorvall SW 55 Ti rotor. Purified
mitochondria were collected at the 1.0 M/1.7 M sucrose
interface. The collected band was resuspended in MIB and
centrifuged at 19000 g for 15 min. The pellet was
resuspended in MIB and centrifuged at 10200 g for 10 min.
The pellet was resuspended twice more in MIB and
recentrifuged at 8200 g for 10 min. The collected pellet
contained purified mitochondria. The protein concentration
of isolated mitochondria was determined by the Dc Protein
Assay using BSA standards (Bio-Rad).
Materials for MS
Synthetic phospholipids including 14:1-14:1 PtdCho (phos-
phatidylcholine), 16:1-16:1 PtdEtn (phosphatidylethanola-
mine), 15:0-15:0 PtdGro (1,2-dipentadecanoyl-sn-glycero-3-
phosphoglycerol), 14:0-14:0 PtdSer (1,2-dimyristoyl-sn-
glycero-3-phosphoserine), N12:0 CerPCho (N-lauroryl
sphingomyelin), T14:0 cardiolipin (1,19,2,29-tetramyristoyl car-
diolipin), N17:0 Cer (heptadecanoyl ceramide) and 17:0
lysoPtdCho (1-heptadecanoyl-2-hydroxy-sn-glycero-3-phos-
phocholine) were purchased from Avanti Polar Lipids. It should
be noted that the prefix ‘N’ denotes the amide-linked acyl
chain. All the solvents were obtained from Burdick and Jackson
(Honeywell International). All other chemicals were purchased
from Sigma–Aldrich.
Sample preparation for mass spectrometric
analysis
An aliquot of the mitochondrial preparation was trans-
ferred to a disposable culture borosilicate glass tube (16
mm6100 mm). Internal standards were added based on
protein concentration and included 16:1-16:1 PtdEtn (100
nmol/mg of protein), 14:1-14:1 PtdCho (45 nmol/mg of
protein), T14:0 cardiolipin (3 nmol/mg of protein), 15:0-
15:0 PtdGro (7.5 nmol/mg of protein), 14:0-14:0 PtdSer
(20 nmol/mg of protein), 17:0 lysoPtdCho (1.5 nmol/mg
protein), N12:0 CerPCho (20 nmol/mg of protein) and
N17:0 Cer (5 nmol/mg of protein). This allowed the final
quantified lipid content to be normalized to the protein
content and eliminated potential loss from incomplete
recovery. The molecular species of internal standards were
selected because they represent ,0.1% of the endogenous
cellular lipid mass as demonstrated by ESI/MS lipid
analysis.
A modified Bligh and Dyer procedure was used to extract
lipids from each mitochondrial preparation as previously
described (Cheng et al., 2006). Each lipid extract was
reconstituted in 500 ml/mg of protein (which was based on
the original protein content of the samples as determined
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127from protein measurement) in chloroform/methanol (1:1;
v/v). The lipid extracts were flushed with nitrogen, capped
and stored at 220˚C for ESI/MS analysis. Each lipid solution
was diluted approx. 50-fold immediately prior to infusion and
lipid analysis.
Instrumentation and MS
A triple-quadrupole mass spectrometer (Thermo Scientific
TSQ Quantum Ultra Plus), equipped with an ESI source and
Xcalibur system software, was utilized as previously
described (Han et al., 2004). The first and third quadrupoles
serve as independent mass analysers using a mass resolution
setting of peak width 0.7 Th, whereas the second
quadrupole serves as a collision cell for MS/MS (tandem
MS). The diluted lipid extract was directly infused into the
ESI source at a flow rate of 4 ml/min with a syringe pump.
Typically, a 2-min period of signal averaging in the profile
mode was employed for each mass spectrum. For MS/MS, a
collision gas pressure was set at 1.0 mT, but the collision
energy varied with the classes of lipids as described
previously (Han et al., 2004; Han and Gross, 2005).
Typically, a 2- to 5-min period of signal averaging in the
profile mode was employed for each MS/MS spectrum. All
the mass spectra and MS/MS spectra were automatically
acquired by a customized sequence subroutine operated
under Xcalibur software. Data processing of two-dimen-
sional MS analyses including ion peak selection, data
transferring, peak intensity comparison and quantification
was conducted using self-programmed Microsoft Excel
macros (Han et al., 2004).
ETC enzyme activities
ETC enzyme analysis for Complex I (NADH-ubiquinone
oxidoreductase), Complex II [succinate decylubiquinone
DCIP (2,6-dichloroindophenol) oxidoreductase], Complex III
(ubiquinol cytochrome c reductase), Complex IV (cytochrome
c oxidase), Complex I/III (NADH cytochrome c reductase) and
Complex II/III (succinate cytochrome c reductase) was
performed as previously described (Ellis et al., 2005; Kiebish
et al., 2008b, 2008c).
RESULTS
We used multiple discontinuous gradients to obtain highly
purified mitochondria from normal brain and from brain
tumour tissue (Kiebish et al., 2008b, 2008c). The length as well
as choice of discontinuous gradients employed was designed
for the purpose of mitochondrial lipid analysis as well as for
assessment of ETC enzyme activities by standard biochemical
procedures. We have recently shown that these isolation
procedures provide precise information on the content and
composition of total mitochondrial lipids when analysed using
shotgun lipidomics (Kiebish et al., 2008b). Mitochondria were
isolated from the brain tumours grown subcutaneouslyin order
to avoid contamination from normal brain tissue surrounding
the tumours. The lipids in tumour mitochondria were compared
with those from NS brain mitochondria, which are largely
derived from glial cells. Part of the in vivo data in the present
study havebeen presentedpreviously(Kiebishet al.,2008a) and
areincludedheretofacilitatecomparisonwiththeinvitrodata.
We also evaluated lipids in mitochondria isolated from the
tumour cells and from non-tumorigenic astrocytes cultured
underidentical conditions. All of the culturedcellsand tumours
were analysed on the same (B6) genetic background. Our
analysis in purified mitochondria eliminates issues regarding
differences in mitochondrial content between tumour tissue
andnormaltissue(Pedersen,1978;Kiebishetal.,2008b,2008c).
The lipid classes were arranged according to their relative
abundance in B6 control brain mitochondria (Table 1).
Table 1 Lipid composition of mitochondria isolated from brain, brain tumour and cells
Values are expressed as mean nmol/mg of protein¡S.D. (n53). *P,0.05; **P,0.01 and ***P,0.001, significantly different values
from B6 NS or astrocyte mitochondria. N.D., not detected.
In vivo In vitro
Lipid Brain
C CT-2A EPEN Astrocyte
C CT-2A EPEN
EtnGpl 187.4¡12.1 245.9¡13.7** 368.4¡46.4* 171.4¡18.6 163.0¡6.5 211.0¡16.7
PtdEtn 164.9¡10.0 137.3¡6.0* 259.4¡45.7 85.9¡3.4 69.7¡3.0** 98.9¡2.3*
PlsEtn 22.5¡2.2 99.3¡7.1** 147.8¡21.4** 80.5¡15.0 87.5¡9.4 106.9¡14.4
PakEtn N.D. 9.3¡0.7** 12.4¡3.0* 5.0¡0.3 5.7¡0.1* 5.1¡1.1
ChoGpl 129.9¡7.7 121.2¡3.6 160.0¡29.5 168.5¡14.2 127.4¡13.2* 194.4¡15.7
PtdCho 119.6¡5.3 81.4¡3.4** 127.4¡25.4 124.6¡10.5 98.1¡12.4* 174.3¡13.9**
PlsCho 1.2¡0.1 19.4¡2.1*** 11.6¡4.8 22.4¡4.0 15.8¡0.8 9.3¡0.8*
PakCho 9.1¡3.2 20.4¡2.6** 17.0¡6.2 21.5¡2.1 13.5¡0.4* 10.8¡1.1**
Cardiolipin 52.7¡4.5 26.1¡1.0** 13.5¡2.7*** 28.3¡4.3 24.6¡3.7 31.1¡4.2
PtdIns 9.4¡0.8 9.5¡2.6 19.4¡2.5* 18.5¡2.4 18.4¡1.6 20.5¡3.3
PtdGro 7.1¡0.5 9.8¡0.5** 16.4¡3.6* 7.7¡2.6 7.6¡1.5 4.7¡0.3
CerPCho 5.3¡1.2 4.6¡0.2 5.8¡1.8 9.7¡1.4 15.9¡3.4 22.1¡1.3**
PtdSer 4.6¡1.5 9.1¡0.6* 10.4¡2.0* 17.8¡0.4 28.7¡5.7 24.1¡3.6
LysoPtdCho 2.7¡0.6 6.3¡0.6** 2.8¡0.4 1.5¡0.1 2.2¡0.4 2.4¡0.6
Cer 0.7¡0.2 2.3¡0.2*** 1.7¡0.2** 0.9¡0.1 1.0¡0.5 2.0¡0.2**
CB6 NS brain mitochondria or astrocyte (C8-D1A) mitochondria were used as controls.
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tumours grown in vivo
The most abundant phospholipid in brain mitochondria is
EtnGpl, which is comprised of PtdEtn, PlsEtn (plasmenyletha-
nolamine) and PakEtn (plasmanylethanolamine). The total
content of EtnGpl was significantly greater in the CT-2A
(31%) and EPEN (97%) tumours than in NS mitochondria
from normal brain (Table 1). Although PtdEtn was lower in
CT-2A than EPEN or normal brain, the significant increase in
total EtnGpl was due to increases in PlsEtn and PakEtn
content compared with brain mitochondria. PlsEtn content
was 4.5- and 6.5-fold higher in CT-2A and EPEN mitochondria
respectively, compared with brain mitochondria. PakEtn was
expressed in both tumours, but was undetectable in brain
mitochondria. Total ChoGpl content was similar in the CT-2A,
EPEN and normal brain mitochondria. However, PtdCho
content was lower, whereas PlsCho (plasmenylcholine) and
PakCho (plasmanylcholine) contents were higher in CT-2A
mitochondria than in normal brain mitochondria.
Cardiolipin content was 2- and 4-fold lower in CT-2A and
EPEN mitochondria respectively, than in normal brain
mitochondria (Table 1). Interestingly, PtdGro (the precursor
for cardiolipin) was increased by 38% and 131% in CT-2A and
EPEN mitochondria respectively, compared with normal brain
mitochondria. PtdIns content was also greater in EPEN
mitochondria than in normal brain mitochondria. The content
of PtdSer and Cer were higher in tumour mitochondria than
in normal brain mitochondria.
Comparison of mitochondrial lipids from brain
tumours grown in vitro
Since many studies of cellular metabolism are conducted in
dividing cells grown in culture, we examined the lipidome of
mitochondria isolated from the brain tumour cells and from
non-tumorigenic syngeneic astrocytes grown under identical
conditions. The growth rate was similar in the astrocytes and
CT-2A cells, but was slower in EPEN cells (Bai and Seyfried,
1997). In contrast with mitochondrial EtnGpl content in the
solid tumours grown in vivo, total mitochondrial EtnGpl
content was similar in the cultured astrocytes and the tumour
cells (Table 1). However, mitochondrial PtdEtn content was
lower in CT-2A and higher in EPEN compared with the
contents in mitochondria from non-tumorigenic astrocytes.
No differences were found in PlsEtn content, whereas PakEtn
content was higher in CT-2A compared with astrocyte
mitochondria. Total mitochondrial ChoGpl content was lower
in CT-2A than in EPEN or astrocytes, primarily due to lower
levels of PtdCho and PakCho. The content of CerPCho and Cer
w a sh i g h e ri nE P E Nm i t o c h o n d r i at h a ni na s t r o c y t e
mitochondria. No differences were detected between non-
tumorigenic astrocytes and tumour cells for the content of
cardiolipin, PtdIns, PtdGro, PtdSer and lysoPtdCho. Viewed
collectively, these findings show that several lipidomic
differences observed between normal mitochondria and
tumour mitochondria in vivo are not found between non-
tumorigenic astrocytes and the tumour cells when grown in
vitro.
Comparisons of lipid molecular species in
mitochondria from normal and tumour tissue
and cells
EtnGpl, ChoGpl and cardiolipin comprised approx. 85–90% of
the total mitochondrial phospholipid content (Table 1).
Differences in the molecular species composition of these
phospholipid classes will therefore represent the most
significant changes to mitochondrial membrane dynamics.
Also, cardiolipin is remodelled using donor fatty acids from
EtnGpl and ChoGpl (Hauff and Hatch, 2006; Xu et al., 2006).
Consequently, abnormalities in mitochondrial EtnGpl and
ChoGpl molecular species will result in alterations of
cardiolipin molecular speciation. The molecular species
composition for all mitochondrial lipids can be found in
Supplementary Tables S1–S9 (at http://www.asnneuro.org/an/
001/an001e011.add.htm). EtnGpl from brain NS mitochondria
contained predominantly D18:1-22:6 and D18:0-20:4/D16:0-
22:4. The first fatty acid species of the pair is presumed to
occupy the sn-1 position, whereas the second species of the
pair is presumed to occupy the sn-2 position. Besides these
major species, approx. 12 other minor molecular species were
also detected (Figure 1). In contrast, EtnGpl from the CT-2A
and EPEN tumours contained predominantly D18:0-18:1/
D16:0-20:1 with lower amounts of D18:0-20:4/D16:0-22:4.
The content of molecular species with low mass-to-charge
ratios, representing less unsaturated and shorter chain fatty
acids, was greater in the CT-2A and the EPEN tumours than in
normal brain mitochondria. In contrast, the distribution of
EtnGpl molecular species was similar in the cultured
astrocytes and in tumour cells, with no molecular species
representing a predominant type (Figure 1).
The predominant ChoGpl molecular species in normal brain
mitochondria were D16:0-18:1, D18:2-18:2/D16:0-20:4,
D16:0-22:6/D18:2-20:4 and D18:2-20:2/D18:0-20:4. These
species were also present in the CT-2A and EPEN tumours, but
their content was less than that found in normal brain
mitochondria (Figure 2). The molecular species of mitochon-
drial ChoGpl were similar in the astrocytes and tumour cells
grown in vitro, with a predominance of D16:0-18:1, D16:1-
16:0/D14:1-18:0, D18:0-18:2/D18:1-18:1 and D18:0-18:1
species. However, the D18:2-20:2/D18:0-20:4 species was
higher in EPEN cells than in astrocytes (Figure 2).
Normal mouse brain cardiolipin contains a unique
distribution of molecular species represented by seven major
species groups, which are conserved and generated following
extensive remodelling (Cheng et al., 2008; Kiebish et al.,
2008b). The distribution of cardiolipin molecular species
differs markedly between normal brain mitochondria and
tumour mitochondria (Figure 3) (Kiebish et al., 2008a). In
general, the content of molecular species with low mass-to-
charge ratios, representing shorter chain less unsaturated
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129molecular species, was greater in the mitochondria from the
CT-2A and EPEN tumours than in mitochondria from normal
brain. These low mass-to-charge species probably represent
newly synthesized cardiolipin. Also, the number of molecular
species groups was noticeably less in the CT-2A tumour than
in the EPEN tumour, suggesting that remodelling abnormal-
ities are greater in CT-2A than in EPEN. The total number of
cardiolipin molecular species was similar in the EPEN tumour
and in normal brain, but their relative distribution in EPEN
was markedly abnormal in showing a predominance of
shorter chain less unsaturated molecular species as demon-
strated by the relative lower mass-to-charge ratios (Figure 3).
The distribution of molecular species in cardiolipin is
influenced by remodelling from EtnGpl, ChoGpl and acyl
CoA fatty acids, as well as by cellular growth rate (Hauff and
Hatch, 2006; Xu et al., 2006). The distribution of cardiolipin
molecular species in the non-tumorigenic astrocytes was
more similar to that of the EPEN and CT-2A tumour cells than
Figure 1 Distribution of EtnGpl molecular species in mitochondria isolated from mouse brain, brain tumours and cultured cells
Molecular species values are arranged based on the mass-to-charge ratio and are expressed as percentages. The mass content of
molecular species can be found in Supplementary Table S1 at http://www.asnneuro.org/an/001/an001e011.add.htm. All values are
expressed as the mean of three independent mitochondrial preparations. The in vivo data were obtained from pooling six mouse
cerebral cortexes or four brain tumours. The in vitro data were obtained from pooling three independent cell pellets, where each
pellet was collected from six T150 culture flasks.
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fatty acid molecular species were found in cardiolipin from
tumour cells grown in vitro, but were not found in cardiolipin
from the solid tumours grown in vivo, suggesting that
hydroxylated fatty acids are produced as an artifact of the in
vitro environment. No v29 fatty acid (mead acid) was found
in the mitochondrial lipids of these brain tumours. Although
mead acid was previously found in some cancers (Tocher et
al., 1995), there are no reports to our knowledge describing
mead acid in primary brain tumours.
ETC activities of brain, brain tumours and cells
grown in culture
ETC activities were measured in mitochondria isolated from
brain and brain tumours grown in vivo, as well as from the
Figure 2 Distribution of ChoGpl molecular species in mitochondria isolated from mouse brain, brain tumours and cultured cells
The mass content of molecular species can be found in Supplementary Table S2 at http://www.asnneuro.org/an/001/
an001e011.add.htm. Other conditions are as described in the legend to Figure 1.
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131cells grown in vitro. Both unlinked and linked ETC enzyme
activities were examined. The activities of Complex I, II, I/III
and II/III were significantly lower in mitochondria from the
CT-2A and the EPEN tumours than in mitochondria from
normal host brain tissue (Figure 5) (Ellis et al., 2005; Kiebish
et al., 2008a). The activity of Complex III was lower only in
EPEN, whereas no significant difference was found between
the tumours and the normal brain tissue for the activity of
Figure 3 Distribution of cardiolipin molecular species in mitochondria isolated from mouse brain and brain tumours
The corresponding mass content of molecular species can be found in Supplementary Table S3 at http://www.asnneuro.org/an/001/
an001e011.add.htm. The distribution of cardiolipin molecular species of tumours grown in vivo have been presented previously and are
shown here only for comparison with the data for the cultured cells shown in Figure 4. Other conditions are as described in the legend to
Figure 1. reproduced from Kiebish et al., 2008a with permission. E 2008, American Society for Biochemistry and Molecular Biology, Inc.
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grown in vitro
Conditions are as described in the legend to Figure 1.
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133Complex IV. The general differences found in the ETC
activities in vivo between the tumour tissue and the normal
tissue were also found between the non-tumorigenic
astrocytes and tumour cells in vitro, with the exception of
Complex I activity (Figure 5). Complex I activity was markedly
lower in the mitochondria from the cultured astrocytes than
in the mitochondria from the brain tissue. Indeed, the
Complex I activity of the cultured astrocytes was more similar
to the activities of the tumour cells than to those of the brain
tissue. These findings indicate that the brain tumour tissue
and the cultured tumour cells contain major abnormalities in
the activities of most ETC Complex activities. These findings
also show that Complex I activity is significantly lower in
mitochondria from cultured astrocytes than in mitochondria
from normal brain tissue.
DISCUSSION
Cultured brain tumour cells and non-tumorigenic astrocytes
are routinely used for studies of energy metabolism and
physiology (Homburg et al., 1961; Rodriguez-Enriquez et al.,
2006; Wu et al., 2007; Schieke et al., 2008). Mitochondrial
membrane lipids are critical for maintaining numerous
Figure 5 ETC enzyme activities in purified mitochondria from mouse brain, brain tumours and cultured tumour cells
Enzyme activities are expressed as nmol/min per mg of protein as described in the Materials and methods section. B, C, E and A
represent enzyme activities from brain, CT-2A, EPEN and astrocytes (non-tumorigenic) respectively. Other conditions are as described
in the legend to Figure 1. Asterisks indicate that the activities in the brain tumour samples differ from those of the control samples
(either mouse brain or astrocytes) at the *P,0.03 or **P,0.005 levels as determined using the two-tailed Student’s t test. The ETC
activities of tumours grown in vivo have been presented previously (reproduced from Kiebish et al., 2008a with permission; E 2008,
American Society for Biochemistry and Molecular Biology, Inc.), and are presented here only for comparison with the enzyme
activities of the cultured cells.
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1985; Hoch, 1992; Shinzawa-Itoh et al., 2007). Cardiolipin, in
particular, regulates ETC activities of Complex I, III, IV and V, as
well as regulating supercomplex formation (Fry and Green,
1980, 1981; Chicco and Sparagna, 2007; Bogdanov et al., 2008;
Kocherginsky, 2008). Additionally, cardiolipin regulates proton
leak and the mitochondrial transport of several bioenergetic
molecules to include adenine nucleotide, carnitine, pyruvate
and phosphate (Hoch, 1998; Chicco and Sparagna, 2007;
Claypool et al., 2008; Kocherginsky, 2008). Abnormalities in
cardiolipin content and composition will decrease cellular
bioenergetic efficiency (Bogdanov et al., 2008; Kocherginsky,
2008). The extent to which the in vitro growth environment
influences the mitochondrial lipidome in non-tumorigenic
astrocytes and in brain tumour cells is largely unknown.
In the present study we have found that the mitochondrial
lipidome of the CT-2A and EPEN brain tumour cells grown in
vitro differed markedly from the mitochondrial lipidome of
these same brain tumour cells when they were grown in vivo.
In addition, the mitochondrial lipidome of non-tumorigenic
astrocytes differed from that of NS brain mitochondria,
which are derived largely from glial cells (Kiebish et al.,
2008b). Indeed, the mitochondrial lipidome of the non-
tumorigenic astrocytes was remarkably similar to that of the
brain tumour cells. Since efficiency of oxidative phosphor-
ylation is dependent on the integrity of the mitochondrial
lipidome, and especially on the content and composition of
cardiolipin, our results indicate that in vitro growth reduces
respiratory energy efficiency in these cells.
The effect of passage number, culture conditions and
cellular differentiation on fatty acid composition has been
extensively studied in transformed and primary cell lines
(Murphy and Horrocks, 1993; Murphy et al., 1993, 1997;
Cheng et al., 2008). However, no prior studies have examined
the influence of growth environment on the mitochondrial
lipidome and ETC activities in brain tumour cell lines
compared with syngeneic non-tumorigenic astrocytes grown
under identical conditions (Springer, 1980; Kunz-Schughart
et al., 2001). Respiratory efficiency is dependent to a large
extent on the expression of mature cardiolipin, which is
synthesized through an extensive remodelling process
(Kiebish et al., 2008c). The abundance of immature cardiolipin
(short chain saturated/monounsaturated species) indicates
that energy through oxidative phosphorylation is compro-
mised in the cultured cells. The markedly reduced ETC
activities, especially those associated with Complex I, is
consistent with a failure to produce mature cardiolipin. The
persistent expression of immature cardiolipin would dissipate
the electrochemical concentration gradient, contribute to
mitochondrial uncoupling, and reduce energy production
through oxidative phosphorylation (Brookes et al., 1998;
Hoch, 1998; Bogdanov et al., 2008; Kocherginsky, 2008). In
addition, low amounts of long-chain polyunsaturated fatty
acids in choline and ethanolamine glycerophospholipids in
brain tumour tissue will prevent cardiolipin remodelling to
the extent seen in normal non-tumorigenic tissue (Hostetler
et al., 1976; Yates et al., 1979; Hartz et al., 1982; Canuto et
al., 1989; Campanella, 1992). Accumulation of the cardiolipin
precursor, PtdGro, also suggests problems with cardiolipin
remodelling and synthesis. An inability to synthesize mature
cardiolipin will therefore reduce energy production through
oxidative phosphorylation.
Further support for respiratory energy inefficiency in the
cultured cells comes from our results that lactic acid
production is high in the CT-2A tumour cells and the non-
tumorigenic astrocytes when grown under identical in vitro
growth conditions (L. Shelton and T.N. Seyfried, unpublished
data), indicating that these cells obtain their energy largely
from glycolysis. In addition to enhanced glycolysis, an
impaired mitochondrial lipidome could also enhance energy
production through glutaminolysis and substrate level
phosphorylation in the TCA (tricarboxylic acid) cycle itself
(DeBerardinis et al., 2007). This energy source, together with
glycolysis, could compensate for the energy lost through
respiration in order to preserve cell viability (Schwimmer et
al., 2005). Viewed collectively, our findings indicate that the
in vitro growth environment produces lipidomic and ETC
abnormalities in non-tumorigenic astrocytes and in brain
tumour cells, which would compromise energy production
through oxidative phosphorylation.
Otto Warburg first proposed that cancer originated from
irreversible injury to cellular respiration that was accompanied
by a gradual dependence on glycolytic energy to compensate
for the energy lost from respiration (Warburg, 1956; Kiebish et
al., 2008a). A dependence on glycolytic energy in the presence
of oxygen is known generally as the ‘Warburg effect’ and is the
metabolic hallmark of nearly all tumour cells (Warburg, 1956;
Kiebish et al., 2008a). Using shotgun lipidomics, we recently
proposed that abnormal cardiolipin could underlie the
irreversible respiratory injury in brain tumours, thus linking
mitochondrial lipid defects to aerobic glycolysis and the
Warburg theory of cancer (Kiebish et al., 2008a). However,
high levels of glucose and other metabolites in culture media
can also increase glycolysis and inhibit oxidative phosphoryla-
tion. This effect was first described by Herbert Crabtree in the
late 1920s and is referred to as the ‘Crabtree effect’ (Crabtree,
1929; Guppy et al., 1993; Frezza and Gottleib, 2008). We do not
exclude the possibility that the lipidomic and ETC abnormalities
observed in the cultured non-tumorigenic astrocytes and brain
tumour cells could arise in part from the Crabtree effect. It is
interesting that several lipidomic differences found between
the brain tumour mitochondria and the NS mitochondria in the
in vivo environment are not seen between the brain tumour
cells and non-tumorigenic astrocytes in the in vitro envir-
onment.Wesuggestthatrapidcellproliferationinvitroandthe
Crabtree effect could obscure or mask lipidomic abnormalities
betweennormaland tumourcellsduetotumorigenesis.Further
studies will be needed to test this hypothesis.
The content and molecular composition of EtnGpl and
ChoGpl is critical for maintaining mitochondrial membrane
fluidity and enzyme activities (Daum, 1985). Fatty acids in the
sn-2 position of mitochondrial EtnGpl and ChoGpl can be used
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135as donor acyl chains for cardiolipin remodelling. Consequently,
the distribution of cardiolipin molecular species will reflect the
acyl chain composition of these glycerophospholipids (Xu et al.,
2003). Shorter chain fatty acids with less unsaturation are
generally more abundant in phospholipids from tumour cells
thanfromnormalcells(Bergelsonetal.,1970,1974;Yatesetal.,
1979; Canuto et al., 1989). This could arise indirectly from the
Warburg effect. Consequently, abnormalities in cardiolipin
remodelling can arise in part from disturbances in the content
and composition of fatty acids in EtnGpl and ChoGpl. In
addition to defects in cardiolipin remodelling using sn-2 fatty
acidsfromEtnGplandChoGpl,wedo notexcludethepossibility
that the abnormalities in fatty acid synthesis, resulting from
respiratory damage and glycolytic dependence, could also
contribute to the expression of abnormal fatty acids in
cardiolipin. We also use caution in our interpretation of
dynamic metabolic events based on static data. Nevertheless,
our findings show multiple lipidomic abnormalities in brain
tumour cells and in cultured non-tumorigenic astrocytes that
could compromise energy metabolism.
Shotgun lipidomic analysis of EtnGpl and ChoGpl sub-
classes allows for identification of glycerophospholipids
containing vinyl ether linkages (plasmalogens). Plasmalogen
glycerophospholipid content is greater in brain tumours than
in normal cells (Slagel et al., 1967; Wood and Healy, 1970;
Wood et al., 1970; Albert and Anderson, 1977; Yates et al.,
1979). Also, cell differentiation state is known to influence
plasmalogen content (Murphy et al., 1997). In the present
study, we found that the content of PlsEtn and PlsCho was
significantly greater in mitochondria from the CT-2A and
EPEN tumours grown in vivo than in the NS brain
mitochondria. Since plasmalogen lipids possess antioxidant
properties, elevated plasmalogen levels in tumour mitochon-
dria could act to buffer free radical production (Zoeller et al.,
1988; Paltauf, 1994; Beal et al., 1997; Carew and Huang,
2002). Additionally, elevated plasmalogen levels could
compensate for the alterations in other mitochondrial lipids,
which could improve membrane structure (Paltauf, 1994;
Gorgas et al., 2006). Elevated plasmalogen concentrations,
however, were only found in the tumours grown in vivo, but
not in the cultured tumour cell lines compared with controls.
In summary, the results of the present study show that the in
vitro growth environment can significantly alter the mitochon-
drial lipidome and ETC activities of brain tumour cells and non-
tumorigenic astrocytes. These abnormalities are expected to
produce a physiological state different from that which would
exist in the in vivo environment. In contrast with the tumour
cells, the lipidomic alterations in the astrocytes might not be
permanent since these cells are non-tumorigenic. The altera-
tions from the culture environment would reduce energy
production through oxidative phosphorylation, thus increasing
substrate level phosphorylation to maintain cell viability. In the
case of brain tumour cells, growth in the culture environment
could obscure lipidomic abnormalities arising from tumorigen-
esis, which can confound the relationship of altered energy
metabolism to tumorigenesis.
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